283 related articles for article (PubMed ID: 29721179)
1. Glypican-1 is enriched in circulating-exosomes in pancreatic cancer and correlates with tumor burden.
Frampton AE; Prado MM; López-Jiménez E; Fajardo-Puerta AB; Jawad ZAR; Lawton P; Giovannetti E; Habib NA; Castellano L; Stebbing J; Krell J; Jiao LR
Oncotarget; 2018 Apr; 9(27):19006-19013. PubMed ID: 29721179
[TBL] [Abstract][Full Text] [Related]
2. Exosomal glypican-1 is elevated in pancreatic cancer precursors and can signal genetic predisposition in the absence of endoscopic ultrasound abnormalities.
Moutinho-Ribeiro P; Batista IA; Quintas ST; Adem B; Silva M; Morais R; Peixoto A; Coelho R; Costa-Moreira P; Medas R; Lopes S; Vilas-Boas F; Baptista M; Dias-Silva D; Esteves AL; Martins F; Lopes J; Barroca H; Carneiro F; Macedo G; Melo SA
World J Gastroenterol; 2022 Aug; 28(31):4310-4327. PubMed ID: 36159010
[TBL] [Abstract][Full Text] [Related]
3. Exosomal glypican-1 discriminates pancreatic ductal adenocarcinoma from chronic pancreatitis.
Moutinho-Ribeiro P; Adem B; Batista I; Silva M; Silva S; Ruivo CF; Morais R; Peixoto A; Coelho R; Costa-Moreira P; Lopes S; Vilas-Boas F; Durães C; Lopes J; Barroca H; Carneiro F; Melo SA; Macedo G
Dig Liver Dis; 2022 Jul; 54(7):871-877. PubMed ID: 34840127
[TBL] [Abstract][Full Text] [Related]
4. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer.
Melo SA; Luecke LB; Kahlert C; Fernandez AF; Gammon ST; Kaye J; LeBleu VS; Mittendorf EA; Weitz J; Rahbari N; Reissfelder C; Pilarsky C; Fraga MF; Piwnica-Worms D; Kalluri R
Nature; 2015 Jul; 523(7559):177-82. PubMed ID: 26106858
[TBL] [Abstract][Full Text] [Related]
5. High levels of serum glypican-1 indicate poor prognosis in pancreatic ductal adenocarcinoma.
Zhou CY; Dong YP; Sun X; Sui X; Zhu H; Zhao YQ; Zhang YY; Mason C; Zhu Q; Han SX
Cancer Med; 2018 Nov; 7(11):5525-5533. PubMed ID: 30358133
[TBL] [Abstract][Full Text] [Related]
6. Elevated glypican-1 expression is associated with an unfavorable prognosis in pancreatic ductal adenocarcinoma.
Lu H; Niu F; Liu F; Gao J; Sun Y; Zhao X
Cancer Med; 2017 Jun; 6(6):1181-1191. PubMed ID: 28440066
[TBL] [Abstract][Full Text] [Related]
7. Glypican-1 and glycoprotein 2 bearing extracellular vesicles do not discern pancreatic cancer from benign pancreatic diseases.
Lucien F; Lac V; Billadeau DD; Borgida A; Gallinger S; Leong HS
Oncotarget; 2019 Feb; 10(10):1045-1055. PubMed ID: 30800217
[TBL] [Abstract][Full Text] [Related]
8. Glypican-1 Is a Novel Target for Stroma and Tumor Cell Dual-Targeting Antibody-Drug Conjugates in Pancreatic Cancer.
Tsujii S; Serada S; Fujimoto M; Uemura S; Namikawa T; Nomura T; Murakami I; Hanazaki K; Naka T
Mol Cancer Ther; 2021 Dec; 20(12):2495-2505. PubMed ID: 34583978
[TBL] [Abstract][Full Text] [Related]
9. EVI1 modulates oncogenic role of GPC1 in pancreatic carcinogenesis.
Tanaka M; Ishikawa S; Ushiku T; Morikawa T; Isagawa T; Yamagishi M; Yamamoto H; Katoh H; Takeshita K; Arita J; Sakamoto Y; Hasegawa K; Kokudo N; Fukayama M
Oncotarget; 2017 Nov; 8(59):99552-99566. PubMed ID: 29245923
[TBL] [Abstract][Full Text] [Related]
10. A novel complement-fixing IgM antibody targeting GPC1 as a useful immunotherapeutic strategy for the treatment of pancreatic ductal adenocarcinoma.
Busato D; Capolla S; Durigutto P; Mossenta M; Bozzer S; Sblattero D; Macor P; Dal Bo M; Toffoli G
J Transl Med; 2023 Nov; 21(1):864. PubMed ID: 38017492
[TBL] [Abstract][Full Text] [Related]
11. Glypican-1 in exosomes as biomarker for early detection of pancreatic cancer.
Herreros-Villanueva M; Bujanda L
Ann Transl Med; 2016 Feb; 4(4):64. PubMed ID: 27004211
[TBL] [Abstract][Full Text] [Related]
12. CD63-GPC1-Positive Exosomes Coupled with CA19-9 Offer Good Diagnostic Potential for Resectable Pancreatic Ductal Adenocarcinoma.
Buscail E; Chauvet A; Quincy P; Degrandi O; Buscail C; Lamrissi I; Moranvillier I; Caumont C; Verdon S; Brisson A; Marty M; Chiche L; Laurent C; Vendrely V; Moreau-Gaudry F; Bedel A; Dabernat S
Transl Oncol; 2019 Nov; 12(11):1395-1403. PubMed ID: 31400579
[TBL] [Abstract][Full Text] [Related]
13. High Clinical Value of Liquid Biopsy to Detect Circulating Tumor Cells and Tumor Exosomes in Pancreatic Ductal Adenocarcinoma Patients Eligible for Up-Front Surgery.
Buscail E; Alix-Panabières C; Quincy P; Cauvin T; Chauvet A; Degrandi O; Caumont C; Verdon S; Lamrissi I; Moranvillier I; Buscail C; Marty M; Laurent C; Vendrely V; Moreau-Gaudry F; Bedel A; Dabernat S; Chiche L
Cancers (Basel); 2019 Oct; 11(11):. PubMed ID: 31717747
[TBL] [Abstract][Full Text] [Related]
14. Extracellular Vesicular Analysis of Glypican 1 mRNA and Protein for Pancreatic Cancer Diagnosis and Prognosis.
Li H; Chiang CL; Kwak KJ; Wang X; Doddi S; Ramanathan LV; Cho SM; Hou YC; Cheng TS; Mo X; Chang YS; Chang HL; Cheng W; Tsai WN; Nguyen LTH; Pan J; Ma Y; Rima XY; Zhang J; Reategui E; Chu YS; Chang PM; Chang PH; Huang CF; Wang CH; Shan YS; Li CP; Fleisher M; Lee LJ
Adv Sci (Weinh); 2024 Mar; 11(11):e2306373. PubMed ID: 38204202
[TBL] [Abstract][Full Text] [Related]
15. A glypican-1-targeted antibody-drug conjugate exhibits potent tumor growth inhibition in glypican-1-positive pancreatic cancer and esophageal squamous cell carcinoma.
Munekage E; Serada S; Tsujii S; Yokota K; Kiuchi K; Tominaga K; Fujimoto M; Kanda M; Uemura S; Namikawa T; Nomura T; Murakami I; Hanazaki K; Naka T
Neoplasia; 2021 Sep; 23(9):939-950. PubMed ID: 34332450
[TBL] [Abstract][Full Text] [Related]
16. Correlation of glypican-1 expression with TGF-beta, BMP, and activin receptors in pancreatic ductal adenocarcinoma.
Kayed H; Kleeff J; Keleg S; Jiang X; Penzel R; Giese T; Zentgraf H; Büchler MW; Korc M; Friess H
Int J Oncol; 2006 Nov; 29(5):1139-48. PubMed ID: 17016645
[TBL] [Abstract][Full Text] [Related]
17. Glypican-1-targeted and gemcitabine-loaded liposomes enhance tumor-suppressing effect on pancreatic cancer.
Mu Y; Wang D; Bie L; Luo S; Mu X; Zhao Y
Aging (Albany NY); 2020 Oct; 12(19):19585-19596. PubMed ID: 33035197
[TBL] [Abstract][Full Text] [Related]
18. The Proteoglycan Glypican-1 as a Possible Candidate for Innovative Targeted Therapeutic Strategies for Pancreatic Ductal Adenocarcinoma.
Busato D; Mossenta M; Dal Bo M; Macor P; Toffoli G
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142190
[TBL] [Abstract][Full Text] [Related]
19. Serum exosomal and serum glypican-1 are associated with early recurrence of pancreatic ductal adenocarcinoma.
Zhao J; Guo M; Song Y; Liu S; Liao R; Zhang Y; Zhang Y; Yang Q; Gu Y; Huang X
Front Oncol; 2022; 12():992929. PubMed ID: 36313694
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of glypican-1 for patients with advanced pancreatic cancer following regional intra-arterial chemotherapy.
Qian JY; Tan YL; Zhang Y; Yang YF; Li XQ
Oncol Lett; 2018 Jul; 16(1):1253-1258. PubMed ID: 29963198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
